Borongan, Daniela B.
HRN: 23-87-35 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/19/2023
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
10/19/2023
10/21/2023
IV
4.5g
Q6
PID
Waiting Final Action
Indication: Empiric Type of Infection: Intra-abdominal Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes